Senior insider sale
Chief Scientific Officer at MEREO BIOPHARMA GROUP PLC — senior position signals high conviction
$106.1K
26.65K shares
What this filing means
LEWICKI JOHN A. plans to sell 26.65K shares of MEREO BIOPHARMA GROUP PLC valued at approximately $106.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/20/2024ACC: 0000950170-24-075613
Officer· Chief Scientific Officer
Since Feb 2026
26.65K
Shares to sell
$106.1K
Approx. market value
69K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Same Day Cashless Exercise and Sale
Equity Compensation
6/21/2024
69KTotal acquired69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/21/2024 | Same Day Cashless Exercise and Sale Equity Compensation | 69K | — |
| Total | 69K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
26.65K
Market value
$106.1K
6/21/2024
Total
Units
26.65K
Value
$106.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/21/2024 | 26.65K | $106.1K | Nasdaq | Planned |
| Total | 26.65K | $106.1K | ||